Asia Pacific Healthcare Bioconvergence Market Size, Share & Industry Trends Analysis Report By Application (Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics), By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Healthcare Bioconvergence Market, by Application
1.4.2 Asia Pacific Healthcare Bioconvergence Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Healthcare Bioconvergence Market by Application
3.1 Asia Pacific Drug Discovery Market by Country
3.2 Asia Pacific Precision Medicine Market by Country
3.3 Asia Pacific Regenerative Medicine Market by Country
3.4 Asia Pacific Diagnostic & Biological Sensors Market by Country
3.5 Asia Pacific Bioelectronics Market by Country
3.6 Asia Pacific Nanorobotics for Drug Delivery Market by Country
3.7 Asia Pacific Engineered Living Materials Market by Country
3.8 Asia Pacific Optogenetics Market by Country

Chapter 4. Asia Pacific Healthcare Bioconvergence Market by Country
4.1 China Healthcare Bioconvergence Market
4.1.1 China Healthcare Bioconvergence Market by Application
4.2 Japan Healthcare Bioconvergence Market
4.2.1 Japan Healthcare Bioconvergence Market by Application
4.3 India Healthcare Bioconvergence Market
4.3.1 India Healthcare Bioconvergence Market by Application
4.4 South Korea Healthcare Bioconvergence Market
4.4.1 South Korea Healthcare Bioconvergence Market by Application
4.5 Singapore Healthcare Bioconvergence Market
4.5.1 Singapore Healthcare Bioconvergence Market by Application
4.6 Malaysia Healthcare Bioconvergence Market
4.6.1 Malaysia Healthcare Bioconvergence Market by Application
4.7 Rest of Asia Pacific Healthcare Bioconvergence Market
4.7.1 Rest of Asia Pacific Healthcare Bioconvergence Market by Application

Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview